Key Highlights

  • Silicon Labs (SLAB) reported second-quarter Revenue of $228 million, up 18% year over year, with non-GAAP Earnings Per Share of $0.71 versus $0.11 a year earlier, a 545% improvement.
  • The company remains under a pending $231-a-share, roughly $7.5 billion all-cash Acquisition by Texas Instruments announced in February, which has suspended forward guidance.
  • On a GAAP basis the company is still posting a loss, $0.32 a share, narrowed from a $0.67 loss a year earlier, highlighting the gap between adjusted and statutory profitability.
  • Shares traded around $218.57, a spread of under 6% to the $231 offer price, with the deal's closing gated by a still-pending regulatory filing in China.

The Rebound Turned Up, Just Not the Drama

Anyone waiting for fireworks from Silicon Laboratories (NASDAQ:SLAB) got the numbers without the theater. The wireless chip designer reported revenue of $228 million for the quarter ended 4 July, up 18% year over year, and non-GAAP diluted earnings of $0.71 a share against $0.11 in the same quarter of 2025. That is a 545% improvement, ahead of the roughly $0.58 that had been circulating as consensus going in and a little above the $0.70 that some trackers recorded as the Street's number on the day.

The muted reaction had nothing to do with the chips. Silicon Labs agreed in February to be acquired by Texas Instruments for $231 a share in cash, valuing the Business at about $7.5 billion. The recovery investors spent two years waiting for has finally shown up in the accounts, and it now belongs to somebody else.

Which EPS You Are Reading Matters Enormously

That large consensus beat was a non-GAAP number, and the distinction is not academic. On a GAAP basis Silicon Labs is still losing money: a diluted loss of $0.32 a share, improved from a $0.67 loss a year earlier, but a loss all the same. GAAP operating loss came in at $11 million while non-GAAP Operating Income was $27 million. The roughly $38 million bridge between the two is chiefly share-based compensation, intangible amortization and acquisition-related costs, all of which the company strips out.

So both descriptions of the quarter are true. Adjusted profitability has rebounded violently from the trough of an industry-wide inventory correction. Statutory profitability has not yet arrived. Investors comparing Silicon Labs with peers should make sure they are holding both companies to the same standard.

Industrial Pulls Ahead of the Home

The split between the two reporting segments tells the recovery story better than the group line does. Industrial & Commercial generated $135 million, up 23%, while Home & Life contributed $93 million, up 12%. That extends the pattern set in the first quarter, when Industrial & Commercial rose 33% to $128 million on electronic shelf labels and smart metering while Home & Life managed only 5% growth. Medical was the standout inside the smaller segment, setting a record with growth of 78%.

Underneath that, the destocking that flattened the whole embedded wireless industry appears genuinely finished. Management said inventory continued to fall at both distributors and end customers, and that bookings and new orders accelerated during the quarter. In April the company reported design wins running ahead of internal targets for a second consecutive record quarter, with book-to-bill at a multi-year high. Those are leading indicators; the revenue line is the lagging one.

Margins Recovering, Balance Sheet Clean

Gross Margin was 61.6% on a GAAP basis and 61.9% adjusted, up from 59.5% and 59.7% respectively three months earlier, better than two percentage points of sequential expansion, driven by Volume filling out a Fixed Cost base rather than by pricing heroics. Operating expenses were $151 million on a GAAP basis and $114 million adjusted, against $144 million and $109 million in the first quarter, so costs are creeping up as revenue recovers rather than being held flat to manufacture profit.

The balance sheet is unusually uncomplicated for a company of this size. Silicon Labs closed the quarter with $362.2 million of cash and equivalents plus $35.1 million of short-term investments and no Debt outstanding; the convertible notes that once sat on the books have gone. Inventory stood at $123.3 million. The one blemish is cash generation: Operating Cash Flow for the first six months was a negative $9.6 million, a reminder that Working Capital absorbs money when a semiconductor business is ramping back up.

Texas Instruments Now Owns the Story

There is no third-quarter outlook, because there is no longer a standalone company to forecast. Silicon Labs suspended forward-looking guidance when the Texas Instruments deal was announced on 4 February and has not restored it. Shareholders approved the Merger on 30 April. Texas Instruments expects roughly $450 million of annual Manufacturing and operational synergies within three years of closing, largely by moving Silicon Labs' production into its own fabs, and has said it expects the deal to be accretive in the first full year after completion.

Closing is guided to the first half of 2027, and the gating item is regulatory rather than financial. Reports in June indicated China's antitrust regulator had not formally accepted the filing weeks after it was submitted. Both parties have meaningful Chinese revenue, Silicon Labs at roughly 15% of sales, Texas Instruments around 20%, which gives Beijing Leverage in a transaction between two American chipmakers.

Competition, and How Much Is Already in the Price

The competitive backdrop is improving for everyone, which slightly deflates the achievement. Nordic Semiconductor reported second-quarter revenue of $219 million on 6 August, up 33% and ahead of forecasts, with gross margin at 53% and third-quarter guidance of $220 million to $240 million. Nordic grew faster than Silicon Labs; Silicon Labs earns a far higher gross margin. NXP and Texas Instruments itself compete at the higher-integration end, while a Chinese rival continues to squeeze pricing on Wi-Fi and combination parts at the low end, precisely the pressure that Texas Instruments' manufacturing scale is meant to answer once the two companies are combined.

Conclusion

For shareholders, none of this is really the point any more. The stock changed hands at about $218.57, against a 52-week range of $115.51 to $220.90, having jumped roughly 49% when the bid landed in February. That leaves a spread of a little under 6% to the $231 offer, and the analyst consensus sits at Hold with an average target of $222.86, effectively the deal price, discounted for time and risk. What is priced in is not an IoT recovery. It is the probability of a Chinese regulator saying yes.